{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:38:00Z","timestamp":1776872280250,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fc receptors are known to have a pivotal role in the initiation and regulation of many immunological and inflammatory processes. This study aimed to investigate the association of Fc receptor family gene polymorphisms with ocular Beh\u00e7et\u2019s disease (BD) in Han Chinese. A two stage case\u2013control study was performed in 1022 BD cases and 1803 healthy controls. Twenty-three SNPs were genotyped using the MassARRAY system (Sequenom), TaqMan SNP Genotyping Assay and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The expression of FCGR3A was examined by real-time PCR and cytokine production was measured by enzyme linked immunosorbent assay (ELISA). A significantly higher frequency of the FCGR3A\/rs428888 CT genotype (Pc\u2009=\u20091.96\u2009\u00d7\u200910<jats:sup>\u22127<\/jats:sup>, OR\u2009=\u20091.897) and a lower frequencies of CC genotype and C allele (Pc\u2009=\u20091.96\u2009\u00d7\u200910<jats:sup>\u22127<\/jats:sup>, OR\u2009=\u20090.527; Pc\u2009=\u20097.22\u2009\u00d7\u200910<jats:sup>\u22127<\/jats:sup>, OR\u2009=\u20090.554 respectively) were found in ocular BD as compared with controls. Functional experiments showed an increased FCGR3A expression (P\u2009=\u20090.005) and increased cytokine protein expressions of MCP-1, IL-1\u03b2 and TNF-\u03b1 by LPS stimulated PBMCs in CT carriers of FCGR3A rs428888 compared to CC carriers (P\u2009=\u20090.034; P\u2009=\u20090.025; P\u2009=\u20090.04; respectively). Our findings demonstrate that FCGR3A\/rs428888 confers genetic susceptibility for ocular BD in Han Chinese.<\/jats:p>","DOI":"10.1038\/s41598-018-23222-8","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T16:42:06Z","timestamp":1520959326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of the association between Fc receptor family gene polymorphisms and ocular Beh\u00e7et\u2019s disease in Han Chinese"],"prefix":"10.1038","volume":"8","author":[{"given":"Donglei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guannan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aize","family":"Kijlstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"key":"23222_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ophtha.2007.04.056","volume":"115","author":"P Yang","year":"2008","unstructured":"Yang, P. et al. Clinical features of Chinese patients with Behcet\u2019s disease. Ophthalmology. 115, 312\u2013318 (2008).","journal-title":"Ophthalmology."},{"key":"23222_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.autrev.2010.10.002","volume":"10","author":"AG Commodaro","year":"2011","unstructured":"Commodaro, A. G., Bueno, V., Belfort, R. Jr. & Rizzo, L. V. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation. Autoimmun Rev. 10, 205\u2013209 (2011).","journal-title":"Autoimmun Rev."},{"key":"23222_CR3","first-page":"S6","volume":"19","author":"A Gul","year":"2001","unstructured":"Gul, A. Behcet\u2019s disease: an update on the pathogenesis. Clinical and experimental rheumatology. 19, S6\u201312 (2001).","journal-title":"Clinical and experimental rheumatology."},{"key":"23222_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/09273948.2012.723112","volume":"20","author":"M Khairallah","year":"2012","unstructured":"Khairallah, M., Accorinti, M., Muccioli, C., Kahloun, R. & Kempen, J. H. Epidemiology of Behcet disease. Ocul Immunol Inflamm. 20, 324\u2013335 (2012).","journal-title":"Ocul Immunol Inflamm."},{"key":"23222_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"de Pineton","year":"2012","unstructured":"Pineton, de et al. New insights into the pathogenesis of Behcet\u2019s disease. Autoimmun Rev. 11, 687\u201398 (2012).","journal-title":"Autoimmun Rev."},{"key":"23222_CR6","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00439-012-1200-4","volume":"131","author":"S Hou","year":"2012","unstructured":"Hou, S. et al. Two-stage association study in Chinese Han identifies two independent associations in CCR1\/CCR3 locus as candidate for Beh\u00e7et\u2019s disease susceptibility. Hum Genet. 131, 1841\u201350 (2012).","journal-title":"Hum Genet."},{"key":"23222_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers, E. F. et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R, IL12RB2 regions associated with Behcet\u2019s disease. Nature genetics. 42, 698\u2013702 (2010).","journal-title":"Nature genetics."},{"key":"23222_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/ard.2009.108571","volume":"69","author":"A Meguro","year":"2010","unstructured":"Meguro, A. et al. Genetics of Behcet disease inside and outside the MHC. Ann.Rheum. Dis. 69, 747\u2013754 (2010).","journal-title":"Ann.Rheum. Dis."},{"key":"23222_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-007-8064-8","volume":"35","author":"M Melikoglu","year":"2008","unstructured":"Melikoglu, M., Kural-Seyahi, E., Tascilar, K. & Yazici, H. The unique features of vasculitis in Behcet\u2019s syndrome. Clin Rev Allerg Immu. 35, 40\u201346 (2008).","journal-title":"Clin Rev Allerg Immu."},{"key":"23222_CR10","first-page":"S16","volume":"28","author":"J Kim","year":"2010","unstructured":"Kim, J. et al. Imbalance of Th17 to Th1 cells in Behcet\u2019s disease. Clin. Exp Rheumatol. 28, S16\u201319 (2010).","journal-title":"Clin. Exp Rheumatol."},{"key":"23222_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nm1585","volume":"13","author":"A Amadi-Obi","year":"2007","unstructured":"Amadi-Obi, A. et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1. Nat Med. 13, 711\u2013718 (2007).","journal-title":"Nat Med."},{"key":"23222_CR12","first-page":"510","volume":"26","author":"C Mantas","year":"1999","unstructured":"Mantas, C., Direskeneli, H., Eksioglu-Demiralp, E. & Akoglu, T. Serum levels of Th2 cytokines IL-4 and IL-10 in Behcet\u2019s disease. J. Rheumatol. 26, 510\u2013512 (1999).","journal-title":"J. Rheumatol."},{"key":"23222_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cyto.2013.06.022","volume":"63","author":"H Belguendouz","year":"2013","unstructured":"Belguendouz, H. et al. B cell activation during Beh\u00e7et disease: Possible BAFF involvement in pathogenesis. Cytokine. 63, 247 (2013).","journal-title":"Cytokine."},{"key":"23222_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/rheumatology\/kew366","volume":"56","author":"TB van der Houwen","year":"2017","unstructured":"van der Houwen, T. B. et al. Chronic signs of memory B cell activation in patients with Beh\u00e7et\u2019s disease are partially restored by anti-tumour necrosis factor treatment. Rheumatology. 56, 134\u2013144 (2017).","journal-title":"Rheumatology."},{"key":"23222_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3109\/s10165-008-0057-9","volume":"18","author":"S Sadreddini","year":"2008","unstructured":"Sadreddini, S., Noshad, H., Molaeefard, M. & Noshad, R. Treatment of retinal vasculitis in Beh\u00e7et\u2019s disease with rituximab. Mod Rheumatol. 18, 306\u20138 (2008).","journal-title":"Mod Rheumatol."},{"key":"23222_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn, F. & Ravetch, J. V. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 8, 34\u201347 (2008).","journal-title":"Nat Rev Immunol."},{"key":"23222_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(08)60671-9","volume":"57","author":"MD Hulett","year":"1994","unstructured":"Hulett, M. D. & Hogarth, P. M. Molecular basis of Fc receptor function. Adv Immunol. 57, 1\u2013127 (1994).","journal-title":"Adv Immunol."},{"key":"23222_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/0-387-46530-8_14","volume":"596","author":"GR Ehrhardt","year":"2007","unstructured":"Ehrhardt, G. R. et al. Fc receptor-like proteins (FCRL): immunomodulators of B cell function. Adv exp med boil. 596, 155\u2013162 (2007).","journal-title":"Adv exp med boil."},{"key":"23222_CR19","doi-asserted-by":"publisher","first-page":"20736","DOI":"10.1073\/pnas.1109227109","volume":"108","author":"JM Kelley","year":"2011","unstructured":"Kelley, J. M. et al. IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci USA 108, 20736\u201320741 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"23222_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrg2571","volume":"10","author":"IT Harley","year":"2009","unstructured":"Harley, I. T. et al. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet. 10, 285\u2013290 (2009).","journal-title":"Nat Rev Genet."},{"key":"23222_CR21","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/hmg\/ddm194","volume":"16","author":"ZA Behrooz","year":"2007","unstructured":"Behrooz, Z. A. et al. Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes,celiac disease and rheumatoid arthritis. Human Molecular Genetics. 16, 2552\u20132559 (2007).","journal-title":"Human Molecular Genetics."},{"key":"23222_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ng.2220","volume":"44","author":"Y Onouchi","year":"2012","unstructured":"Onouchi, Y. et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 44, 517\u2013521 (2012).","journal-title":"Nat Genet."},{"key":"23222_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jneuroim.2008.01.004","volume":"195","author":"F Matesanz","year":"2008","unstructured":"Matesanz, F. et al. The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis. J Neuroimmunol. 195, 146\u2013150 (2008).","journal-title":"J Neuroimmunol."},{"key":"23222_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ng.479","volume":"41","author":"S Raychaudhuri","year":"2009","unstructured":"Raychaudhuri, S. et al. Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk. Nat Genet. 41, 1313\u20131318 (2009).","journal-title":"Nat Genet."},{"key":"23222_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10067-012-2028-y","volume":"31","author":"Z Zeng","year":"2012","unstructured":"Zeng, Z. et al. Association of FCRL4 polymorphisms on disease susceptibility and severity of ankylosing spondylitis in Chinese Han population. Clin Rheumatol. 31, 1449\u20131454 (2012).","journal-title":"Clin Rheumatol."},{"key":"23222_CR26","first-page":"S77","volume":"26","author":"K Aksu.","year":"2008","unstructured":"Aksu., K. et al. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Beh\u00e7et\u2019s disease: do they have any clinical implications? Clin Exp Rheumatol. 26, S77\u201383 (2008).","journal-title":"Clin Exp Rheumatol."},{"key":"23222_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.101","volume":"45","author":"SJ Kim","year":"2013","unstructured":"Kim, S. J. et al. Targeted resequencing of candidate genes reveals novel variants associated with severe Beh\u00e7et\u2019s uveitis. Exp Mol Med. 45, e49 (2013).","journal-title":"Exp Mol Med."},{"key":"23222_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H. & Lambrecht, B. N. The function of Fc\u03b3 receptors in dendritic cells and macrophages. Nature Reviews Immunology. 14, 94\u2013108 (2014).","journal-title":"Nature Reviews Immunology."},{"key":"23222_CR29","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3899\/jrheum.080186","volume":"35","author":"YH Lee","year":"2008","unstructured":"Lee, Y. H., Ji, J. D. & Song, G. G. Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a meta analysis. J Rheumatol. 35, 2129\u201335 (2008).","journal-title":"J Rheumatol."},{"key":"23222_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/0961203308089407","volume":"17","author":"F Pan","year":"2008","unstructured":"Pan, F. et al. Genetic susceptibility and haplotype analysis between Fcgamma receptor IIB and IIIA gene with systemic lupus erythematosus in Chinese population. Lupus. 17, 733\u20138 (2008).","journal-title":"Lupus."},{"key":"23222_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1034\/j.1600-065X.2002.19009.x","volume":"190","author":"RS Davis","year":"2002","unstructured":"Davis, R. S. et al. Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev. 190, 123\u201336 (2002).","journal-title":"Immunol Rev."},{"key":"23222_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/art.22270","volume":"54","author":"WG Newman","year":"2006","unstructured":"Newman, W. G. et al. Rheumatoid Arthritis Association With the FCRL3 \u2013169\u2009C Polymorphism Is Restricted to PTPN22 1858T\u2013Homozygous Individuals in a Canadian Population. Arthritis Rheum. 54, 12 (2006).","journal-title":"Arthritis Rheum."},{"key":"23222_CR33","doi-asserted-by":"crossref","unstructured":"Wellcome Trust Case Control Consortium et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics. 39, 1329\u20131337(2007).","DOI":"10.1038\/ng.2007.17"},{"key":"23222_CR34","first-page":"2136","volume":"14","author":"L Ke","year":"2008","unstructured":"Ke, L. et al. Association between polymorphisms of FCRL3, a non-HLA gene, and Beh\u00e7et\u2019s disease in a Chinese population with ophthalmic manifestations. Molecular Vision. 14, 2136\u20132142 (2008).","journal-title":"Molecular Vision."},{"key":"23222_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-005-0353-8","volume":"25","author":"T Takai","year":"2005","unstructured":"Takai, T. Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol. 25, 1\u201318 (2005).","journal-title":"J Clin Immunol."},{"key":"23222_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0065-2776(07)96005-8","volume":"96","author":"F Nimmerjahn","year":"2007","unstructured":"Nimmerjahn, F. & Ravetch, J. V. Fc-receptors as regulators of immunity. Adv Immunol. 96, 179\u2013204 (2007).","journal-title":"Adv Immunol."},{"key":"23222_CR37","first-page":"588","volume":"19","author":"Y Suzuki","year":"1992","unstructured":"Suzuki, Y., Hoshi, K., Matsuda, T. & Mizushima, Y. Increased peripheral blood gamma delta\u00fe T cells and natural killer cells in Behcet\u2019s disease. J Rheumatol. 19, 588\u2013592 (1992).","journal-title":"J Rheumatol."},{"key":"23222_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2249.2004.02536.x","volume":"137","author":"HG Yu","year":"2004","unstructured":"Yu, H. G. et al. The number of CD8\u00fe T cells and NKT cells increases in the aqueous humor of patients with Behcet\u2019s uveitis. Clin Exp Immunol. 137, 437\u2013443 (2004).","journal-title":"Clin Exp Immunol."},{"key":"23222_CR39","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.4049\/jimmunol.175.9.6133","volume":"175","author":"JK Ahn","year":"2005","unstructured":"Ahn, J. K., Chung, H., Lee, D. S., Yu, Y. S. & Yu, H. G. CD8bright CD56\u00fe T cells are cytotoxic effectors in patients with active Behcet\u2019s uveitis. J Immunol. 175, 6133\u20136142 (2005).","journal-title":"J Immunol."},{"key":"23222_CR40","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/ar3005","volume":"12","author":"Y Yamaguchi","year":"2010","unstructured":"Yamaguchi, Y. et al. Natural killer cells control a T-helper 1 response in patients with Behcet\u2019s disease. Arthritis Res Ther. 12, R80 (2010).","journal-title":"Arthritis Res Ther."},{"key":"23222_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nri1004","volume":"3","author":"B Beutler","year":"2003","unstructured":"Beutler, B. & Rietschel, E. T. Innate immune sensing andits roots:the story of endotoxin. Nat Rev Immunol. 3, 169\u201376 (2003).","journal-title":"Nat Rev Immunol."},{"key":"23222_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"YC Lu","year":"2008","unstructured":"Lu, Y. C., Yeh, W. C. & Ohashi, P. S. LPS\/TLR4 signal transduction pathway. Cytokine. 42, 145\u201351 (2008).","journal-title":"Cytokine."},{"key":"23222_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","volume":"223","author":"LA Tesmer","year":"2008","unstructured":"Tesmer, L. A., Lundy, S. K., Sarkar, S. & Fox, D. A. Th17 cells in human disease. Immunol. Rev. 223, 87\u2013113 (2008).","journal-title":"Immunol. Rev."},{"key":"23222_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoui","year":"2002","unstructured":"Hamzaoui, K. et al. Cytokine profile in Behcet\u2019s diseas epatients.Relationship with disease activity. Scand.J. Rheumatol. 31, 205\u2013210 (2002).","journal-title":"Scand.J. Rheumatol."},{"key":"23222_CR45","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Behcet\u2019s disease. International Study Group for Behcet\u2019s Disease. Lancet. 335, 1078\u201380 (1990).","DOI":"10.1016\/0140-6736(90)92643-V"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23222-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:43:12Z","timestamp":1671594192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23222-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["23222"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-23222-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,19]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4850"}}